Uttam Sugar Mills Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 5, 2025, 4:40 am

Competitors of Uttam Sugar Mills Ltd

All Competitor Stocks of Uttam Sugar Mills Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:40 am

Below is a detailed analysis of the quarterly data for Uttam Sugar Mills Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 605.00 Cr.. The value appears strong and on an upward trend. It has increased from 550.00 Cr. (Mar 2025) to 605.00 Cr., marking an increase of 55.00 Cr..
• For Expenses, as of Jun 2025, the value is 554.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 435.00 Cr. (Mar 2025) to 554.00 Cr., marking an increase of 119.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 51.00 Cr.. The value appears to be declining and may need further review. It has decreased from 115.00 Cr. (Mar 2025) to 51.00 Cr., marking a decrease of 64.00 Cr..
• For OPM %, as of Jun 2025, the value is 8.00%. The value appears to be declining and may need further review. It has decreased from 21.00% (Mar 2025) to 8.00%, marking a decrease of 13.00%.
• For Other Income, as of Jun 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 19.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2025) to 19.00 Cr., marking an increase of 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 89.00 Cr. (Mar 2025) to 21.00 Cr., marking a decrease of 68.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 25.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 68.00 Cr. (Mar 2025) to 16.00 Cr., marking a decrease of 52.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 4.18. The value appears to be declining and may need further review. It has decreased from 17.81 (Mar 2025) to 4.18, marking a decrease of 13.63.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:12 am

Growth

Last Updated: September 5, 2025, 1:50 pm

Balance Sheet

Last Updated: June 16, 2025, 11:08 am

Below is a detailed analysis of the balance sheet data for Uttam Sugar Mills Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 38.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 38.00 Cr..
• For Reserves, as of Mar 2025, the value is 736.00 Cr.. The value appears strong and on an upward trend. It has increased from 658.00 Cr. (Mar 2024) to 736.00 Cr., marking an increase of 78.00 Cr..
• For Borrowings, as of Mar 2025, the value is 775.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 761.00 Cr. (Mar 2024) to 775.00 Cr., marking an increase of 14.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 477.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 327.00 Cr. (Mar 2024) to 477.00 Cr., marking an increase of 150.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,026.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,785.00 Cr. (Mar 2024) to 2,026.00 Cr., marking an increase of 241.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 774.00 Cr.. The value appears to be declining and may need further review. It has decreased from 777.00 Cr. (Mar 2024) to 774.00 Cr., marking a decrease of 3.00 Cr..
• For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For Investments, as of Mar 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2024) to 29.00 Cr., marking an increase of 24.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,222.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,002.00 Cr. (Mar 2024) to 1,222.00 Cr., marking an increase of 220.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,026.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,785.00 Cr. (Mar 2024) to 2,026.00 Cr., marking an increase of 241.00 Cr..

However, the Borrowings (775.00 Cr.) are higher than the Reserves (736.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Uttam Sugar Mills Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 23.16. This value is within the healthy range. It has decreased from 34.67 (Mar 24) to 23.16, marking a decrease of 11.51.
• For Diluted EPS (Rs.), as of Mar 25, the value is 23.16. This value is within the healthy range. It has decreased from 34.67 (Mar 24) to 23.16, marking a decrease of 11.51.
• For Cash EPS (Rs.), as of Mar 25, the value is 34.72. This value is within the healthy range. It has decreased from 45.10 (Mar 24) to 34.72, marking a decrease of 10.38.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 206.20. It has increased from 182.50 (Mar 24) to 206.20, marking an increase of 23.70.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 206.20. It has increased from 182.50 (Mar 24) to 206.20, marking an increase of 23.70.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 484.03. It has decreased from 536.70 (Mar 24) to 484.03, marking a decrease of 52.67.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 58.01. This value is within the healthy range. It has decreased from 71.93 (Mar 24) to 58.01, marking a decrease of 13.92.
• For PBIT / Share (Rs.), as of Mar 25, the value is 45.79. This value is within the healthy range. It has decreased from 61.50 (Mar 24) to 45.79, marking a decrease of 15.71.
• For PBT / Share (Rs.), as of Mar 25, the value is 30.94. This value is within the healthy range. It has decreased from 46.88 (Mar 24) to 30.94, marking a decrease of 15.94.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 22.50. This value is within the healthy range. It has decreased from 34.66 (Mar 24) to 22.50, marking a decrease of 12.16.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.16. This value is within the healthy range. It has decreased from 34.66 (Mar 24) to 23.16, marking a decrease of 11.50.
• For PBDIT Margin (%), as of Mar 25, the value is 11.98. This value is within the healthy range. It has decreased from 13.40 (Mar 24) to 11.98, marking a decrease of 1.42.
• For PBIT Margin (%), as of Mar 25, the value is 9.45. This value is below the healthy minimum of 10. It has decreased from 11.45 (Mar 24) to 9.45, marking a decrease of 2.00.
• For PBT Margin (%), as of Mar 25, the value is 6.39. This value is below the healthy minimum of 10. It has decreased from 8.73 (Mar 24) to 6.39, marking a decrease of 2.34.
• For Net Profit Margin (%), as of Mar 25, the value is 4.64. This value is below the healthy minimum of 5. It has decreased from 6.45 (Mar 24) to 4.64, marking a decrease of 1.81.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.78. This value is below the healthy minimum of 8. It has decreased from 6.45 (Mar 24) to 4.78, marking a decrease of 1.67.
• For Return on Networth / Equity (%), as of Mar 25, the value is 11.22. This value is below the healthy minimum of 15. It has decreased from 18.99 (Mar 24) to 11.22, marking a decrease of 7.77.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.05. This value is within the healthy range. It has decreased from 26.20 (Mar 24) to 17.05, marking a decrease of 9.15.
• For Return On Assets (%), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has decreased from 7.40 (Mar 24) to 4.11, marking a decrease of 3.29.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.09. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.09.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.06. This value exceeds the healthy maximum of 1. It has decreased from 1.09 (Mar 24) to 1.06, marking a decrease of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 1.5. It has increased from 1.11 (Mar 24) to 1.12, marking an increase of 0.01.
• For Quick Ratio (X), as of Mar 25, the value is 0.09. This value is below the healthy minimum of 1. It has increased from 0.06 (Mar 24) to 0.09, marking an increase of 0.03.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 10.79. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 10.79, marking an increase of 10.79.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 7.06. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 7.06, marking an increase of 7.06.
• For Earning Retention Ratio (%), as of Mar 25, the value is 89.21. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 89.21, marking an increase of 89.21.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 92.94. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 92.94, marking an increase of 92.94.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.91. This value is within the healthy range. It has decreased from 4.92 (Mar 24) to 3.91, marking a decrease of 1.01.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.52. This value is below the healthy minimum of 3. It has decreased from 3.37 (Mar 24) to 2.52, marking a decrease of 0.85.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,841.16. It has decreased from 1,943.27 (Mar 24) to 1,841.16, marking a decrease of 102.11.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 1. It has increased from 0.94 (Mar 24) to 0.99, marking an increase of 0.05.
• For EV / EBITDA (X), as of Mar 25, the value is 8.32. This value is within the healthy range. It has increased from 7.08 (Mar 24) to 8.32, marking an increase of 1.24.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 24) to 0.53, marking a decrease of 0.05.
• For Retention Ratios (%), as of Mar 25, the value is 89.20. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 89.20, marking an increase of 89.20.
• For Price / BV (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has decreased from 1.71 (Mar 24) to 1.25, marking a decrease of 0.46.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 24) to 0.53, marking a decrease of 0.05.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 24) to 0.08, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness